AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2019
Jul 29, 2019
33003_dirs_2019-07-29_12ee0122-7edd-4b58-ba47-6c965164b138.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-07-25
Reporting Person: Ganot Ilan (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-25 | Common Stock | A | 21505 | $4.65 | Acquired | 1123631 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 290914 | Indirect |
Footnotes
F1: Represents 1,063,000 shares held by Mr. Ganot as an individual. Represents 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with a right of survivorship.
F2: Represents 209,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19